Form 4: Electromed Director Kathleen A. Tune Acquires 3,000 Shares of Restricted Stock

Director Kathleen A. Tune acquired 3,000 shares of Electromed, Inc. restricted stock on December 1, 2024, which are scheduled to vest on June 1, 2025.

Summary

• Kathleen A. Tune, a director at Electromed, Inc., acquired 3,000 shares of restricted common stock on December 1, 2024.
• The shares were acquired at a price of $0.
• These shares are scheduled to vest on June 1, 2025, unless vesting is accelerated or terminated earlier.
• Following this transaction, Ms. Tune now beneficially owns 12,000 shares of Electromed stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of a director acquiring restricted stock, which is generally viewed as a positive sign of confidence in the company. The sentiment is neutral to slightly positive.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The restricted stock is scheduled to vest on June 1, 2025, unless vesting is accelerated or terminated earlier.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders when they acquire or dispose of company stock. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• The acquisition of restricted stock by directors is a common practice in publicly traded companies as part of their compensation packages.
• The vesting schedule of June 1, 2025, is a typical vesting period for restricted stock grants.
• Similar filings are regularly made by directors and officers of other companies, such as those in the medical device industry, including companies like ResMed and Inogen.

Stakeholder Impact

• The acquisition of shares by a director may positively influence shareholder confidence.

Key Dates

Keywords

Electromed, Director, Kathleen A. Tune, Restricted Stock, Beneficial Ownership, SEC Form 4, ELMD, Stock Acquisition